Northern Trust’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.18M Buy
1,042,641
+117,246
+13% +$245K ﹤0.01% 2936
2025
Q1
$1.58M Buy
925,395
+24,201
+3% +$41.3K ﹤0.01% 3044
2024
Q4
$4.55M Buy
901,194
+92,708
+11% +$468K ﹤0.01% 2560
2024
Q3
$4.4M Buy
808,486
+236,024
+41% +$1.28M ﹤0.01% 2561
2024
Q2
$2.75M Buy
572,462
+22,717
+4% +$109K ﹤0.01% 2732
2024
Q1
$1.71M Sell
549,745
-15,362
-3% -$47.8K ﹤0.01% 3048
2023
Q4
$1.6M Buy
565,107
+46,521
+9% +$132K ﹤0.01% 3110
2023
Q3
$1.52M Buy
518,586
+18,578
+4% +$54.4K ﹤0.01% 3083
2023
Q2
$1.43M Buy
500,008
+14,171
+3% +$40.5K ﹤0.01% 3203
2023
Q1
$1.5M Sell
485,837
-24,065
-5% -$74.4K ﹤0.01% 3068
2022
Q4
$1.08M Buy
509,902
+274,260
+116% +$579K ﹤0.01% 3229
2022
Q3
$769K Sell
235,642
-6,747
-3% -$22K ﹤0.01% 3377
2022
Q2
$777K Buy
242,389
+120,300
+99% +$386K ﹤0.01% 3406
2022
Q1
$862K Sell
122,089
-2,287
-2% -$16.1K ﹤0.01% 3497
2021
Q4
$901K Buy
+124,376
New +$901K ﹤0.01% 3586